Close Menu

 NEW YORK (360Dx) – Thermo Fisher Scientific business BRAHMS today announced it received 510(k) clearance for expanded use of the firm's procalcitonin-sensitive Kryptor assay for antibiotic resistance.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.